Article

Multidisciplinary team studies blinding diseases

Boston-The Schepens Eye Research Institute will form teams of basic and clinical researchers from many disciplines to study blinding eye diseases under a unique grant available from the National Institutes of Health (NIH).

Boston-The Schepens Eye Research Institute will form teams of basic and clinical researchers from many disciplines to study blinding eye diseases under a unique grant available from the National Institutes of Health (NIH).

The program, part of the "NIH Road-map" that seeks to find new ways to solve problems outside traditional research, will create a "think tank" of researchers from Schepens, Massachusetts Eye and Ear Infirmary, Harvard Medical School, and other Harvard teaching hospitals. Researchers will include those studying Alzheimer's disease, rheumatoid arthritis, and heart disease.

The 3-year, nearly $2.2 million grant will fund the planning and piloting phase of what will ultimately be an interdisciplinary research center.

Researchers hope the work will turn up ideas for addressing incurable diseases in other areas of the body.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
1 expert is featured in this series.
© 2025 MJH Life Sciences

All rights reserved.